Ethic Inc’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.78M | Buy |
16,847
+9,766
| +138% | +$5.09M | 0.16% | 133 |
|
|
2025
Q1 | $4.37M | Sell |
7,081
-3,587
| -34% | -$2.21M | 0.09% | 235 |
|
|
2024
Q4 | $7.6M | Buy |
10,668
+4,509
| +73% | +$3.21M | 0.15% | 138 |
|
|
2024
Q3 | $5.93M | Sell |
6,159
-284
| -4% | -$273K | 0.15% | 164 |
|
|
2024
Q2 | $6.77M | Buy |
6,443
+284
| +5% | +$298K | 0.16% | 138 |
|
|
2024
Q1 | $5.93M | Buy |
6,159
+602
| +11% | +$579K | 0.15% | 164 |
|
|
2023
Q4 | $4.88M | Sell |
5,557
-261
| -4% | -$229K | 0.14% | 172 |
|
|
2023
Q3 | $4.79M | Buy |
5,818
+177
| +3% | +$146K | 0.17% | 143 |
|
|
2023
Q2 | $4.05M | Buy |
5,641
+60
| +1% | +$43.1K | 0.15% | 168 |
|
|
2023
Q1 | $4.59M | Buy |
5,581
+2,271
| +69% | +$1.87M | 0.19% | 128 |
|
|
2022
Q4 | $2.39M | Buy |
3,310
+876
| +36% | +$632K | 0.13% | 210 |
|
|
2022
Q3 | $1.68M | Sell |
2,434
-37
| -1% | -$25.5K | 0.11% | 227 |
|
|
2022
Q2 | $1.46M | Buy |
2,471
+542
| +28% | +$320K | 0.1% | 249 |
|
|
2022
Q1 | $1.35M | Buy |
1,929
+404
| +26% | +$282K | 0.09% | 266 |
|
|
2021
Q4 | $963K | Buy |
1,525
+132
| +9% | +$83.4K | 0.07% | 287 |
|
|
2021
Q3 | $843K | Buy |
1,393
+355
| +34% | +$215K | 0.09% | 258 |
|
|
2021
Q2 | $580K | Buy |
1,038
+290
| +39% | +$162K | 0.07% | 306 |
|
|
2021
Q1 | $354K | Sell |
748
-119
| -14% | -$56.3K | 0.06% | 344 |
|
|
2020
Q4 | $419K | Buy |
867
+45
| +5% | +$21.7K | 0.11% | 243 |
|
|
2020
Q3 | $460K | Buy |
822
+221
| +37% | +$124K | 0.18% | 142 |
|
|
2020
Q2 | $375K | Buy |
601
+130
| +28% | +$81.1K | 0.21% | 134 |
|
|
2020
Q1 | $230K | Buy |
+471
| New | +$230K | 0.19% | 165 |
|